Kenvue Inc. hired an executive from Procter & Gamble Co. to help the company get back on track after its biggest product, ...
Texas Attorney General Ken Paxton claims the makers of Tylenol failed to warn consumers of the risks. Here's who makes ...
By Jonathan Stempel (Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney ...
Kenvue (NYSE:KVUE), the consumer healthcare spin-off from Johnson & Johnson, has experienced a significant decline in its ...
Texas Attorney General Ken Paxton is suing the makers of Tylenol over allegedly deceptively marketing the over-the-counter ...
The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, who accused ...
Renaissance Capital's bet on Kenvue is a bold one. The stock has performed poorly since the consumer health business spun off ...
Barchart on MSN
This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?
Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
WEDNESDAY, Oct. 29, 2025 (HealthDay News) — Texas Attorney General Ken Paxton has filed a lawsuit accusing Kenvue, the maker ...
The suit alleges that Kenvue hid autism risks of its popular pain reliever despite doctors saying it is safe to take during ...
Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including the state of Texas suing ...
The lawsuit by Texas Attorney General Ken Paxton comes weeks after U.S. President Donald Trump linked Tylenol use during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results